Recent Posts in Dangerous Drugs And Medical Devices Category
-
Prescribing Medicare Doctors Received Payments from Opioid Manufacturers
Posted By Brett H. Oppenheimer, PLLCContinue Reading
CNN and Harvard researchers analyzed information from a federal government database that tracks payments from pharmaceutical companies (drug companies) to doctors and a separate federal database that tracks prescriptions doctors write for Medicare patients. The results of the analysis found that doctors who were paid the most money from opioid manufacturers tended to prescribe the most opioids. ...
-
Opioids & Neonatal Abstinence Syndrome
Posted By Brett H. Oppenheimer, PLLCContinue Reading
The opioid epidemic is having massive impact, not only on addicts and their loved ones, but also our communities and our resources. Regardless, there is no more innocent victim than a baby born addicted to or in withdrawal from narcotics. Along with the increasing number of people suffering from addiction, there is a shocking increase in newborns diagnosed with Neonatal Abstinence Syndrome (NAS). ...
-
Update on RoundUp® Lawsuits
Posted By Brett H. Oppenheimer, PLLCContinue Reading
There are currently over 300 lawsuits against Monsanto Co., the maker of RoundUp®, consolidated in the US District Court of Northern California under Judge Vince Chhabria. The lawsuits allege that the main ingredient in Roundup®, which is glyphosate, may cause cancer, including non-Hodgkin’s Lymphoma, in people who are frequently exposed to the weed-killer. These cases make up an MDL, or an ...
-
FARXIGA AND RISKS OF KIDNEY PROBLEMS
Posted By Brett H. Oppenheimer, PLLCWhat is Farxiga®? Farxiga® is one of a class of type II diabetes drugs called Sodium-Glucose Costransporter-2 (SGLT-2) inhibitors. SGLT-2 Inhibitors work by altering the normal kidney function so that less sugar is reabsorbed into the blood and the surplus glucose is excreted through the urine. Farxiga® received FDA approval in January of 2014. Farxiga® was originally developed by Bristol-Myers ...Continue Reading -
FDA Issues Critical Letter to EpiPen for Failure to Address Product Failures
Posted By Brett H. Oppenheimer, PLLCIn early September 2017, the U.S. Food and Drug Administration (FDA) sent a scathing letter to Meridian Medical Technologies rebuking the company for failing to investigate and address component and product failures in its EpiPen products. The FDA cited hundreds of customer complaints that were linked to life-threatening emergencies in which the EpiPen auto-injectors failed to operate correctly. ...Continue Reading -
The Liability of Hospitals and Doctors Printing 3D Medical Devices
Posted By Brett H. Oppenheimer, PLLCThe 3D printing process entails building solid, three-dimensional objects from digital models, using an additive process in which successive layers of material are assembled on top of one another to build a product. As 3D printing becomes more commonplace, it presents several liability questions for those injured by these products and devices. But when a doctor or hospital prints the device at ...Continue Reading -
Study Shows One Third of Drugs Approved by FDA Have Major Safety Concerns
Posted By Brett H. Oppenheimer, PLLCContinue Reading
Pharmaceutical drugs can save lives and offer relief from medical conditions for millions of people in this country. All drug companies must go through an approval process with the Food and Drug Administration (FDA) in order to sell a prescription drug. The process requires laboratory and animal testing and studies using humans. The pharmaceutical company then submits an application to the FDA ...
-
Hernia Surgical Mesh Implants
Posted By Brett H. Oppenheimer, PLLCThere are currently lawsuits filed and being filed on behalf of patients injured by hernia mesh implants. These lawsuits allege that hernia mesh can cause such adverse reactions as organ damage perforation, bowel obstruction, infection, and hernia recurrence. Furthermore, the lawsuits allege that the makers of these hernia mesh implants failed to adequately research these implants, failed to ...Continue Reading -
The Long Term Risks of Proton Pump Inhibitor Drug (PPIs)
Posted By Brett H. Oppenheimer, PLLCPeople with heartburn and acid reflux disease are frequently prescribed medications that help to block or reduce excess stomach acid. These medications are called Proton Pump Inhibitors (PPIs). PPIs include prescribed medications and over-the-counter drugs. PPIs are often very successful in the treatment of heartburn and gastroesophageal reflux disease (GERD), but new research shows that these ...Continue Reading -
New Suit Against Cialis
Posted By Brett H. Oppenheimer, PLLCIn August of 2016 seven men have filed lawsuits against ELI Lilly and Co alleging that they suffered skin cancer as the results of taking Cialis. Cialis is an erectile dysfunction drug. These men join a growing number of lawsuits filed against the makers of erectile dysfunction drugs such Pfizer who manufactures Viagra. These lawsuits claim that Eli Lily and Pfizer should have known of the link ...Continue Reading -
Taxotere: Chemo Drug May Cause Permanent Hair Loss
Posted By Brett H. Oppenheimer, PLLCTaxotere (docetaxel) is a chemotherapy drug prescribed for the treatment of many forms of cancer. While most chemotherapy drugs have a high likelihood of temporary hair loss, Taxotere has been alleged to cause permanent hair loss in many patients. The pharmaceutical company who manufactures Taxotere, Sanofi-Aventis, did not disclose the risk of permanent hair loss to the medical community or the ...Continue Reading -
IVC Filter Injury Lawsuits
Posted By Brett H. OppenheimerContinue Reading
Inferior Vena Cava filters (IVC blood clot filters) have been implanted in about 25,000 patients in the United States annually. Many of these filters are effective in preventing life-threatening blood clots from moving into the heart and lungs. However, the FDA issued a warning in 2010 that Inferior Vena Cava filters that are implanted in patients can move or splinter leading to punctured organs ...
-
What You Need to Know About Talcum Powder
Posted By Brett H. Oppenheimer, PLLCIn February of 2016 Johnson and Johnson was found responsible to pay approximately $72 million (including punitive damages) to the family of a 52 year old woman after a jury found that her use of Johnson & Johnson’s Baby Powder and Johnson & Johnson’s Shower to Shower contributed to her death from ovarian cancer. Most recently another jury awarded another woman $55 million as she too developed ...Continue Reading -
Adolescent Male Diagnosed With Gynecomastia After Taking Risperdal
Posted By Brett H. Oppenheimer, PLLCI received a call from the father of an adolescent male. His son had been diagnosed with ADHD and, among other medications, was prescribed Risperdal. His son had recently been diagnosed with Gynecomastia (male breast growth). The father had learned through an internet search that Gynecomastia is a complication of Risperdal. Unfortunately, in young men who have been prescribed Risperdal and have ...Continue Reading -
Risperdal Causes Young Man to Develop Large Breasts
Posted By Brett H. Oppenheimer, PLLCWe were contacted by the father of a young man who had developed large breasts over the past year or so. This teenager was taking a medication called Risperdal (made by Johnson & Johnson) and had developed a condition called Gynecomastia. He developed breasts that would be typical of a post-puberty female. As it turns out, many cases across the country allege the rapid growth of “female-like” ...Continue Reading -
Male Patient Suffers Pancreatits Complication After Undergoing ERCP
Posted By Brett H. Oppenheimer, PLLCEven though it is less common for a male patient to undergo an ERCP (Endoscopic Retrograde Cholangiopancreatography) than a female patient, sometimes men do undergo this test. This caller was a middle aged male who had undergone an ERCP and had suffered the complications known as pancreatitis. ERCP is a method for doctors to evaluate problems with the patient’s pancreas, gall bladder, bile ducts ...Continue Reading
Page
1 of 1